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Most normal mammalian cells have a finite lifespan 1 , thought to constitute a protective mechanism against unlimited proliferation [2] [3] [4] . This phenomenon, called senescence, is driven by telomere attrition, which triggers the induction of tumour suppressors including p16 INK4a (ref. 5) . In cultured cells, senescence can be elicited prematurely by oncogenes 6 ; however, whether such oncogene-induced senescence represents a physiological process has long been debated. Human naevi (moles) are benign tumours of melanocytes that frequently harbour oncogenic mutations (predominantly V600E, where valine is substituted for glutamic acid) in BRAF 7 , a protein kinase and downstream effector of Ras. Nonetheless, naevi typically remain in a growtharrested state for decades and only rarely progress into malignancy (melanoma) [8] [9] [10] . This raises the question of whether naevi undergo BRAF V600E -induced senescence. Here we show that sustained BRAF V600E expression in human melanocytes induces cell cycle arrest, which is accompanied by the induction of both p16
INK4a and senescence-associated acidic b-galactosidase (SA-b-Gal) activity, a commonly used senescence marker. Validating these results in vivo, congenital naevi are invariably positive for SA-b-Gal, demonstrating the presence of this classical senescence-associated marker in a largely growth-arrested, neoplastic human lesion. In growth-arrested melanocytes, both in vitro and in situ, we observed a marked mosaic induction of p16 INK4a , suggesting that factors other than p16
INK4a contribute to protection against BRAF V600E -driven proliferation. Naevi do not appear to suffer from telomere attrition, arguing in favour of an active oncogene-driven senescence process, rather than a loss of replicative potential. Thus, both in vitro and in vivo, BRAF V600E -expressing melanocytes display classical hallmarks of senescence, suggesting that oncogene-induced senescence represents a genuine protective physiological process.
Melanocytic naevi represent an intriguing human setting where an activated oncogene can co-exist with long-term arrested cells. Naevi are very common, clonal and benign tumours of cutaneous melanocytes 11 , and frequently harbour the V600E mutation in BRAF 7 (NCBI gene bank re-named the V599E mutation based on newly available sequence data; accession number NM_004333.2; hereafter referred to as BRAF E600 ). However, in spite of the oncogenic nature of this mutation 12, 13 , an initial phase of naevus growth is typically followed by a near-complete cessation of proliferative activity, which is maintained for many decades 8, 9, 14 . Therefore, it is conceivable that growth arrest of naevi results from oncogene-induced senescence acting as an effective cellular brake against BRAF E600 -mediated oncogenic signalling.
To test this hypothesis, we first determined the effect of the naevusassociated BRAF E600 mutant on the proliferative capacity of freshly isolated normal human skin melanocytes. A bicistronic lentiviral vector co-expressing BRAF E600 and enhanced green fluorescent protein (eGFP) (to monitor infection efficiency, typically approximately 90%; Fig. 1a ) was used to transduce melanocytes. Short-term expression of BRAF E600 (3-7 days) led to enhanced melanocyte proliferation that was measured by a moderate but reproducible increase in 5-bromodeoxyuridine (BrdU) incorporation (Fig. 1b and data not shown). However, this effect was transient-sustained expression of BRAF E600 resulted in marked cell cycle arrest. In most (roughly 80%) of the transduced melanocytes, this was associated with an intense activity of SA-b-Gal, a marker for senescent or stressed cultured cells as well as for aged tissues in vivo 6, 15 (Fig. 1c) .
The p16
INK4a protein is a major tumour suppressor, often highly expressed in senescent cells in vitro and inactivated in a variety of human cancers, including 30-70% of melanomas 16 . We found that BRAF E600 -expressing melanocytes had elevated levels of p16
INK4a
( Fig. 1d) . Notably, the staining for p16 INK4a was heterogeneous, with 25-35% of the BRAF E600 -expressing melanocytes showing low or undetectable p16
INK4a levels, in spite of the fact that over 95% of these cells were arrested (and still expressed the lentiviral cassette, as evident from eGFP expression).
As oncogene-induced senescence in vitro has been best defined in primary diploid fibroblasts, we analysed the cellular response to activated BRAF in this 'reference' context. Consistent with previous results obtained with overexpression of Ras V12 or Raf1 (refs 6, 17, 18) , retroviral delivery of BRAF E600 into two different strains of normal human fibroblasts caused a complete cessation of proliferation, along with induction of p16
INK4a (see Supplementary Fig. 1a, b) . To exclude the possibility that these effects were caused by supra-physiological levels of BRAF E600 expression, we designed a system in which its expression levels could be manipulated with considerable precision. Cells were transduced with a mixture of retrovirus encoding a BRAF E600 expression cassette and retrovirus encoding a short hairpin (sh)RNA targeting both endogenous wild type and ectopic BRAF E600 (for details, see Fig. 2 legend) . This strategy allowed expression of BRAF E600 to levels similar to those seen in melanoma cells (see Supplementary Fig. 2a ), or to levels close to, or indistinguishable from, endogenous BRAF levels (Fig. 2a , compare lanes 4 and 5).
The elevation of p16
INK4a levels was maintained on progressively diminishing BRAF E600 levels (see Supplementary Fig. 2a ). We did not see upregulation of p14 ARF by BRAF E600 (see Supplementary Fig. 3 ). Furthermore, low levels of BRAF E600 caused inhibition of both DNA replication (see Supplementary Fig. 2b ) and cellular proliferation (Fig. 2b) . This arrest was stably maintained, without any significant escape (see Supplementary Fig. 2c ). However, it was bypassed by coexpression of the SV40 large tumour antigen (see Supplementary  Fig. 2d ), arguing against an aphysiological effect and suggesting that this arrest depends on cellular tumour suppressors. Furthermore, in the context of fibroblasts defective for p53 and p16
INK4a and expressing SV40 small tumour antigen and human telomerase reverse transcriptase (hTERT), BRAF E600 could efficiently substitute for Ras V12 in the induction of tumours in immunocompromised mice (see Supplementary Table 1) .
Recently, overexpression of Ras V12 has been shown to cause accumulation of senescence-associated heterochromatic foci (SAHF), concentrated spots of transcriptionally silenced DNA 19 . We observed that low levels of BRAF E600 also induced SAHF (Fig. 2c ). This was accompanied by focal accumulation of a specific heterochromatin-associated histone modification, namely methylation of lysine 9 of histone H3 (K9M-H3). Together, these results indicate that low levels of BRAF E600 induce senescence-like cell cycle arrest in primary human cells.
To investigate whether p16 INK4a upregulation constitutes a protective response to inappropriate mitogenic signalling by BRAF E600 , we created cell lines stably expressing p16 INK4a shRNA. This shRNA was effective, as it suppressed the accumulation of p16
INK4a in various settings (Fig. 2a) , caused increased proliferation INK4a -independent manner. a-c, Human BJ hTERT cells stably expressing either control or p16
INK4a shRNA were transduced with a mixture of a retrovirus encoding BRAF E600 expression and puromycin resistance cassettes, and a retrovirus encoding cassettes for a shRNA targeting both endogenous wild type and ectopic BRAF E600 and blasticidin resistance (labelled BRAF E600 ). Pharmacological selection for both resistance markers was used to create cells that had stably integrated both the BRAF E600 expression cassette and the shRNA. The latter alone did not affect proliferative potential (data not shown). As a control, cells were transduced with p16
INK4a -encoding retrovirus. a, Analysis by western blotting with b-actin used as a loading control. b, Analysis by proliferation curves. Shown are the results of three independent experiments performed in duplicate with standard deviations. c, DAPI staining to detect SAHF (percentage of SAHF-positive cells is indicated in insert) and immunofluorescence for K9M-H3. Note that whereas p16
INK4a shRNA neutralized senescence induced by ectopic expression of p16 INK4a , it failed to bypass BRAF (see Supplementary Fig. 4 ) and abolished the induction of cell cycle arrest by overexpressed p16 INK4a ( Fig. 2b ; see also Supplementary  Fig. 2b, c) . However, low levels of BRAF E600 inhibited proliferation and induced SAHF even on p16
INK4a depletion ( Fig. 2b, c ; see also Supplementary Fig. 2b, c) . Identical observations were made for a p16
INK4a binding-deficient cyclin-dependent kinase 4 mutant (CDK4 R24C ; see Supplementary Fig. 2e ), for a different fibroblast strain (TIG3; see Supplementary Fig. 2f-h ) and for fibroblasts explanted from a homozygous p16
INK4a
-deficient 'Leiden' patient 20 (see Supplementary Fig. 2i-l) . These results suggest that, at least in cultured human fibroblasts, p16
INK4a is upregulated in response to physiological levels of BRAF E600 , but is not strictly required for the induction of cell cycle arrest.
Next, we wished to validate in vivo our observation that BRAF E600 induces senescence-like arrest in vitro. Given the high frequency of BRAF mutations in both naevi and melanomas 7, 12 , we looked for hallmarks of senescence in a panel of resection specimens of human naevi. We first confirmed the presence of the BRAF E600 mutation in eight specimens of our panel of 23 naevi (see Supplementary Fig. 5 ). We then used paraffin-embedded as well as cryosections of normal human skin and resection specimens of naevi for further analysis. Virtually all melanocytes within these naevi were growth-arrested, as judged by negative immunohistochemical staining for the proliferation marker Ki-67 (Fig. 3a) , in agreement with the literature 8, 9 . This was in contrast to epidermal keratinocytes in the same specimens, many of which showed proliferative activity.
As expression of BRAF E600 in cultured human melanocytes led to cell cycle arrest along with induction of SA-b-Gal activity, we subjected our naevi panel to analysis for this senescence marker.
SA-b-Gal activity has previously been shown to increase in human epidermis as a function of age 15 . To avoid detection of age-induced SA-b-Gal activity, we analysed a panel of congenital naevi obtained from patients under one year of age. Indeed, all 23 naevi analysed displayed high levels of SA-b-Gal activity (Fig. 3a-c) . This activity was absent from normal skin melanocytes within the same samples (Fig. 3b, c) and in control samples taken from normal skin (Fig. 3a) . In agreement with previous data 21 , SA-b-Gal activity was also absent from freshly isolated, cultured primary human melanocytes (Fig. 1c) . Terminally differentiated keratinocytes within the epidermis of the same samples also did not show SA-b-Gal activity (Fig. 3b, c,  arrowheads) , consistent with previous observations made in young (, 39 yr of age) donors 15 . SA-b-Gal activity was similarly lacking from the cells of skin adnexa, such as the sweat gland (Fig. 3b, c , labelled S), and from the dermal mesenchymal cells between the naevus cell nests. Thus, human naevi, largely growth-arrested neoplastic lesions, are positive for the senescence marker SA-b-Gal.
Studies in mouse models and humans indicate that (epi)genetic inactivation of the p16
INK4a gene is associated with melanomagenesis 9, 16, 22, 23 . Normal melanocytes, scattered alongside the dermalepidermal junction and surrounded by keratinocytes, had undetectable levels of p16
INK4a (Fig. 3a) . In contrast, naevi invariably contained p16
INK4a -expressing cells, in agreement with previous observations 9, 22 . Of note, we failed to detect any significant upregulation of p53 and p21 CIP1 in naevi (data not shown). Irrespective of the mutational status of BRAF in the naevi, the percentage of p16
positive cells and the intensity of staining per cell was heterogeneous, with a striking mosaic pattern of p16
INK4a immunopositivity seen in most naevi ( Fig. 3a; see also Supplementary Fig. 6 ; data not shown). Importantly, all melanocytes within these p16
INK4a -mosaic naevi (whether positive or negative for p16 INK4a ) were growth arrested ( Fig. 3a; see also Supplementary Fig. 6 ). Indeed, the lack of proliferation of the naevus melanocytes was associated with positive SA-b-Gal staining rather than with p16
INK4a immunoreactivity, thereby closely mimicking BRAF E600 -expressing melanocytes in vitro. As naevi are thought to be clonal 11 , it is unlikely that a differential BRAF mutation pattern underlies the p16
INK4a mosaicism. The observed p16
INK4a mosaicism is in accordance with the occurrence of growth arrest in naevi of homozygous p16
INK4a -deficient Leiden patients 20 . However, the naevi of these patients are increased in number and size compared to those of p16
INK4a -proficient individuals. Together with the mosaic p16
INK4a pattern seen in BRAF E600 -expressing, growth-arrested melanocytes in vitro, these observations suggest that p16
INK4a collaborates with other, yet-to-be-identified factors in the establishment of long-term growth arrest of naevi. Whether p16
INK4a contributes to an irreversible arrest that, once established, no longer requires p16 INK4a (as has been suggested previously 19, 24 ), or is involved in aspects of melanoma progression other than oncogene-induced senescence remains to be determined. Together these results show that human naevi and BRAF E600 -expressing melanocytes share three senescence-associated markers: stable growth arrest, heterogeneous induction of p16
INK4a and SA-bGal activity.
Although these features support oncogene-induced senescence as the cause for cell cycle arrest of melanocytic naevi, in principle these senescence markers may have been triggered by telomere attrition, which might have resulted from the initial expansion of melanocytes. Indeed, telomere attrition has been previously proposed as a major factor involved in the cell-cycle arrest of naevi 25 . This would be consistent with the clinical observation that congenital naevi (that is, arising before birth) can cover large areas of the body surface, in contrast to naevi acquired later in life, which are usually much smaller. To test this possibility, we performed telomere FISH (fluorescent in situ hybridization) on congenital naevus resections. As expected, melanoma metastases, stained as controls, displayed much less fluorescence than their surrounding stromal cells, indicating that this method is sufficiently sensitive to detect differences in telomere length in situ (Fig. 4a, b ; see also Supplementary Fig. 7 ). In contrast, we did not observe any significant difference in telomere fluorescence when comparing congenital naevi to surrounding tissues, in agreement with previous observations made in acquired and Spitz naevi 26 . Although we cannot formally rule out the possibility that a single eroded telomere may have triggered the senescence response, one would not expect the other telomeres to remain apparently full length. These results argue in favour of an active oncogene-driven senescence process, rather than senescence triggered by exhaustion of replicative potential resulting from gross telomere attrition.
Our observation that BRAF E600 initially stimulates moderate melanocyte proliferation supports the hypothesis that it contributes to the initiating events of melanomagenesis. However, our results suggest that, both in vitro and in vivo, oncogenic BRAF signalling subsequently leads to a growth-inhibitory response, which is associated with the known classical hallmarks of senescence (that is, stable proliferative arrest, an increase in p16
INK4a and the induction of SAb-Gal activity). Our results therefore provide support for a speculative model previously proposed 9, 27 , in which BRAF E600 cannot fully transform human melanocytes, but requires additional, cooperating events for tumour development. Supporting this view, zebrafish expressing a BRAF E600 transgene develop 'fish-naevi', which require a p53-deficient background to progress to invasive melanomas 28 . Our observations provide evidence of oncogene-induced senescence as a physiological mechanism in humans limiting the progression of premalignant lesions.
METHODS
Plasmids. Gene transfer in normal human melanocytes was achieved with two independent lentiviral vectors (FG12-HA-BRAF E600 -eGFP and HIV-CS-CG-BRAF E600 -puro), with comparable phenotypes. pBabe-puro-BRAF E600 was used to transduce fibroblasts.
The p16 INK4a shRNA sequence corresponds to nucleotides 21-41 (GenBank accession number NM_000077). The BRAF shRNA sequence was previously described 29 . Cell culture, retroviral transduction, cell cycle analysis and proliferation curves. Normal human melanocytes were isolated from the epidermis of neonatal foreskins. Briefly, foreskins were incubated overnight in trypsinization solution (22.5 mM HEPES, 7.5 mM glucose, 2.25 mM KCl, 100 mM NaCl, 0.75 mM Na 2 HPO 4 and 0.17% trypsin). Dermis and epidermis were separated by scraping. The epidermal compartment was incubated for 3-4 d in 254CF medium (Cascade Biologicals) supplemented with 0.1 mM CaCl 2 , 2% fetal bovine serum and keratinocyte growth supplement (Cascade Biologicals). Melanocytes were subsequently separated from keratinocytes by differential trypsinization. Purity of the melanocytic preparations was estimated by standard immunostaining for HMB-45. For long-term cultures, melanocytes were propagated in 254CF medium in the presence of 0.2 mM CaCl 2 and melanocyte growth supplement (Cascade Biologicals).
BJ cells expressing hTERT (in pBabeHygro) were grown in DMEM/medium 199 (Gibco) in a 4:1 ratio supplemented with 15% fetal bovine serum (PAA Laboratories), 0.1 mM MEM non-essential amino acids (Gibco), 2 mM glutamine (Gibco), 100 units ml 2 1 penicillin and 0.1 mg ml 2 1 streptomycin.
Lentiviral infections were performed using HEK293T cells as producers of viral supernatants. The Phoenix packaging cell line was used for the generation of ecotropic retroviruses, as described 30 . Amphotropic retroviruses encoding the Figure 4 | No apparent telomere loss in naevi. a, Frozen sections of human naevi and melanomas were subjected to telomere FISH (red). A representative sample is shown; six naevi were analysed (five of which harboured the BRAF E600 mutation). For reference, sections were also stained with the Melan A antibody (detecting melanocytes in naevus and melanoma, green) and DAPI (blue). Note that in the naevus specimen, both the naevus cells (Melan-A positive) and the stromal compartment (Melan-A negative) are FISH positive. In contrast, melanoma tumour cells, which conceivably have undergone telomere attrition, have a much weaker telomere fluorescence signal than their surrounding stromal cells. The channel overlay is shown (individual channels are shown in Supplementary Fig. 7) . b, Quantification of the data in a, plotted as relative telomere fluorescence in six naevi and three melanomas (both indicated as melanocytes) compared to their respective stromal cells (non-melanocytes) with standard deviations. ecotropic receptor were generated in HEK293T cells. All infections were carried out as described 30 . BrdU labelling was carried out for 3 h in reduced growth factor conditions. Proliferation curves were performed as described 6, 30 . Human tissue samples. Surgical resection specimens of congenital naevi were obtained from patients in their first year of life. Specimens were fresh frozen and stored for a period of 2 months to 2 years at 270 8C before use. Analysis of SA-b-galactosidase activity. Tissues were fixed in 4% formaldehyde for 2 h, washed with 0.2% NP-40, 0.1% Na-deoxycholate, 2 mM MgCl 2 , 100 mM Na 2 HPO 4 , pH 6.0 and stained as described 15 . Tissues were post-fixed overnight in 4% formaldehyde and embedded in paraffin. Cultured cells were stained as described 15 . Immunohistochemistry and antibodies. Tissues were fixed in 4% formaldehyde overnight and embedded in paraffin. Paraffin sections were deparaffinized, rehydrated, incubated in 0.1 mM sodium citrate pH 6.0, washed and incubated with peroxidase blocking reagent (S2001; DAKO). The tissue was incubated with the primary antibodies Ab-3 for Melan A (Molecular Probes), MIB-1 for Ki-67 (DAKO) and Ab-4 (16P04) for p16
INK4a (Molecular Probes). Secondary antibody used was PowerVision þ (DPVB þ 999HRP; ImmunoLogic). Peroxidase activity was detected with Liquid DAB (K3468; DAKO).
The antibodies used for western blotting were F-7 for BRAF (sc-5284; Santa Cruz), JC8 (MS-889; NeoMarkers) for p16
INK4a , C-22 for CDK4 (sc-260; Santa Cruz) and AC-74 for b-actin (A5316; Sigma). The antibodies used for immunofluorescence were anti-trimethyl-histone H3 (Lys 9) (07-442; Upstate) and 554070 (BD Pharmingen) for p16 INK4a . DAPI staining was used to visualize nuclei. Telomere FISH. Tissue sections were prepared for FISH analysis with the 2 0 -deoxyoligonucleotide N3 0 ! P5 0 phosphoramidate probe: 5 0 -(CCCTAA) 3 -TAMRA-3 0 , specific for telomeric sequences. The Melan A antibody Ab-3 was used and also the DNA staining dye DAPI. Images of fluorescein (FITC), TAMRA and DAPI fluorescence were acquired on a digital image microscopy system. The relative telomere length is proportional to the number of hybridized probes. For quantification, the fluorescence signal was determined (using ImageJ software) for all individual telomeres within 12 nuclei per specimen, both for melanocytes (within naevi and melanomas) and for cells within the stromal compartments of both types of lesion, for six independent naevi and three independent melanomas. All measurements have been corrected for background nuclear fluorescence.
